Patients with challenging diabetic macular edema may achieve anatomical gains and extended dosing intervals with bispecific faricimab.

Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several ...

Corneal crosslinking (CXL) can be used to treat corneal neovascularization (CNV) if any causative infection is eradicated at the time of treatment or shortly thereafter, according ...